Partners / ADNKRONOS
-
November 4, 2026
Naples, prosecutor Gratteri’s alarm: “10 preliminary investigation judges are missing, by Christmas we will reach 2000 pending requests for precautionary measures”
Naples, Nov 4. (Adnkronos) – “In September, 1300 requests for precautionary measures were pending with the preliminary investigation judge; today there are 1590, and by Christmas we will reach 2000. At least 10 judges are needed in the Preliminary Investigation Judge’s Office, otherwise they cannot keep up with the pace of the Public Prosecutor’s Office”. The alarm was raised by the prosecutor of Naples, Nicola Gratteri, who spoke during a press conference to illustrate the results of an operation conducted by the Naples Police Headquarters’ mobile squad and the Pianura police station, with 28 arrests of three different clans in the Pianura neighborhood. “I already mentioned it in September – […]
-
November 4, 2026
Link Campus University awards Luca Beccari the ‘Excellence in Economy, Health and Society’ prize
Rome, Nov 4. – (Adnkronos) – Link Campus University of Rome awarded the ‘Excellence in Economy, Health and Society’ Prize to Luca Beccari, Secretary of State for Foreign Affairs, Political Affairs, International Economic Cooperation and Digital Transition of the Republic of San Marino. The ceremony took place during a meeting which, in front of an audience mainly composed of diplomatic representatives from many countries, featured the President of the Council of State, Luigi Maruotti, who underlined the importance of San Marino in the international context, the Italian Deputy Minister of Foreign Affairs and International Cooperation, Edmondo Cirielli, who spoke about bilateral relations between Italy and San Marino, and Ambassador Giampiero […]
-
November 4, 2026
Energy, Dell’Acqua (Arera): “Self-sufficiency to reduce vulnerability to geopolitical crises”
Rimini, Nov 4. (Adnkronos) – “We must continue with the planning, with the Pniec, which say that in two or three years we will have greater energy self-sufficiency than we have today, and geopolitical fluctuations will influence us less. We need to move forward with infrastructure for alternatives (solar, wind, hydro, etc.): it is not just a correct ecological necessity, but a necessity for self-sufficiency. Materials that we can produce at home, and the energy mix will be able to balance any other geopolitical moments, like the current one. We must proceed with infrastructural investments and continue to invest in gas, even if we know perfectly well that it has […]
-
November 4, 2026
Ispra at Ecomondo, strategies to regenerate soils and protect the sea
Rimini, Nov 4. (Adnkronos) – Environmental restoration and marine protection. Ispra brings to Ecomondo its role in the landscape of environmental research and expertise and its commitment to promoting scientific knowledge in support of ecological transition. The 2026 edition of the Report on Land Consumption in Italy, the work curated by the Italian Institute for Environmental Protection and Research (Ispra) and the National System for Environmental Protection (Snpa), this year not only measures the phenomenon but also provides a first national mapping of potentially recoverable land. According to the data, with over 2,100 sq km of available surfaces, Italy can begin to recover land and create new urban green spaces, […]
-
November 4, 2026
Petruzzelli (Aladdin’s Lamp): “Oncological treatments should be equal for everyone, regardless of the territory”
Rome, 4 Nov. (Adnkronos Health) – “Even in oncology, innovation is alive and is changing the quantity and quality of life. For us patients, however, it is fundamental that new treatments arrive quickly and certainly, and that access to care does not depend on the postal code. We cannot accept that the quality and quantity of care are conditioned by the territory in which one lives.” This was stated by Davide Petruzzelli, president of La Lampada di Aladino Ets and vice-president of Favo, at the ‘Generating innovation. Creating health’ meeting in Rome, during which the winning projects of the fifth edition of the Gilead Calls were announced. Petruzzelli also indicated […]
-
November 4, 2026
Rome: Gianfranco Minissale is the new head of the Flying Squad, ‘not a single hand behind the 18 bombs’/Adnkronos (2)
(Adnkronos) – Minissale, 62, originally from the province of Messina, joined the Public Security administration in 1990. After the training course for Police officials, he began his investigative career at the Palermo police headquarters, where he also held the position of head of the Investigative Section of the Zisa sectional police station and, subsequently, that of director of the Corleone police station. During his long and qualified career, he gained consolidated experience in combating organized crime, distinguishing himself particularly in anti-mafia investigative activities. At the Palermo Flying Squad, he first directed the Fugitive Section and, subsequently, the Organized Crime Section, contributing to complex judicial police operations and the capture of […]
-
November 4, 2026
Gianfranco Minissale is the new head of Rome’s flying squad: “Not a single hand behind the 18 bombs”
Rome, Nov 4. (Adnkronos) – “Not all of the 18 bombs we have recorded in recent months are attributable to a single criminal design.” Gianfranco Minissale, today the new head of the Roman flying squad, meeting the press, immediately addresses the issue of the devices exploded in various areas of Rome, precisely 18 in four months, which have created a certain alarm among the population. So much so that in East Rome, citizens have repeatedly taken to the streets with various torchlight processions against organized crime. It is a “contested territory” always “because there the drug dealing squares have offered the greatest profitability,” he said. And among the recent episodes, […]
-
November 4, 2026
Drugs: Prix Galien Italy to Italfarmaco for therapy in rare disease (3)
(Adnkronos Health) – “The results of the first preclinical studies, on mouse models with Duchenne muscular dystrophy, were significant – explains Paolo Bettica, Chief Medical Officer, Drug Development Italfarmaco –. From here, the clinical development of the molecule began. In collaboration with patient associations and Italian clinicians, we designed a phase 2 study that allowed us to evaluate the effect of givinostat directly in the muscle, thanks to muscle biopsies performed after one year of treatment. This phase 2 study was conducted entirely in Italy. The observed results were very positive because they replicated what was observed in the murine model. We then promoted an international phase 3 registration study, […]
-
November 4, 2026
Drugs: Prix Galien Italy to Italfarmaco for therapy in rare disease (2)
(Adnkronos Health) – “The fruit of Italian research, givinostat – reads the award’s motivation – represents a therapeutic innovation in Duchenne muscular dystrophy because it introduces a different mechanism of action, independent of the specific genetic mutation, with potential applicability to a broad population of eligible patients according to authorized indications. In association with corticosteroids, it has been shown to slow the progression of the disease and contribute to the more prolonged maintenance of motor function and autonomy, addressing a significant therapeutic need in the field of rare diseases, with a significant impact on the quality of life of patients and their families.” Duchenne muscular dystrophy is a rare genetic […]
-
November 4, 2026
Prix Galien Italy to Italfarmaco for therapy in rare disease
Rome, Nov 4. (Adnkronos Health) – Givinostat, a molecule that “has been shown in clinical studies to slow down the progression of Duchenne muscular dystrophy” thanks to a new mechanism of action, wins the Prix Galien Italy in the ‘Rare Diseases’ category. The drug – a note informs – represents a story of Italian scientific excellence and is the result of Italfarmaco’s research and development. The award ceremony took place yesterday in Turin. “The victory of the Prix Galien rewards not only an innovative molecule like givinostat, but also an entrepreneurial and scientific history built over time through constant investments in research and development – explains Francesco Di Marco, Group […]